Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort
- 1 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 100 (4), 903-911
- https://doi.org/10.1007/s00277-021-04422-1
Abstract
Hyperbilirubinemia in patients with sickle cell anemia (SCA) as a result of enhanced erythrocyte destruction, lead to cholelithiasis development in a subset of patients. Evidence suggests that hyperbilirubinemia may be related to genetic variations, such as the UGT1A1 gene promoter polymorphism, which causes Gilbert syndrome (GS). Here, we aimed to determine the frequencies of UGT1A1 promoter alleles, alpha thalassemia, and βS haplotypes and analyze their association with cholelithiasis and bilirubin levels. The UGT1A1 alleles, −3.7 kb alpha thalassemia deletion and βS haplotypes were determined using DNA sequencing and PCR-based assays in 913 patients with SCA. The mean of total and unconjugated bilirubin and the frequency of cholelithiasis in GS patients were higher when compared to those without this condition, regardless of age (P < 0.05). Cumulative analysis demonstrated an early age-at-onset for cholelithiasis in GS genotypes (P < 0.05). Low fetal hemoglobin (HbF) levels and normal alpha thalassemia genotype were related to cholelithiasis development (P > 0.05). However, not cholelithiasis but total and unconjugated bilirubin levels were associated with βS haplotype. These findings confirm in a large cohort that the UGT1A1 polymorphism influences cholelithiasis and hyperbilirubinemia in SCA. HbF and alpha thalassemia also appear as modulators for cholelithiasis risk.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#483714/2013–5)
This publication has 54 references indexed in Scilit:
- The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy PatientsPLOS ONE, 2013
- Early Complication in Sickle Cell Anemia Children due toA(TA)nTAAPolymorphism at the Promoter ofUGT1A1GeneDisease Markers, 2013
- Polymorphic Variants of UGT1A1 in Neonatal Jaundice in Southern BrazilJournal of Tropical Pediatrics, 2010
- Definitions of the phenotypic manifestations of sickle cell diseaseAmerican Journal of Hematology, 2009
- DNA polymorphisms at the BCL11A , HBS1L-MYB , and β- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- UGT1A1(TA)n promoter polymorphism—A new case of a (TA)8 allele in CaucasiansBlood Cells, Molecules, and Diseases, 2007
- Sickle Cell Disease: A Multigenic Perspective of a Single Gene DisorderHemoglobin, 2007
- UGT1A1 polymorphism outweighs the modest effect of deletional (−3.7 kb) α‐thalassemia on cholelithogenesis in sickle cell anemiaAmerican Journal of Hematology, 2006
- Influence of α-Thalassemia on Cholelithiasis in SS Patients with Elevated Hb FActa Haematologica, 1998
- Gall stones in homozygous sickle cell disease.Archives of Disease in Childhood, 1989